Tenapanor
Products Tenapanor was approved in the United States in tablet form in 2019 (Ibsrela). Structure and properties Tenapanor (C50H66Cl4N8O10S2, Mr = 1145 g/mol) is present in the drug as tenapanor hydrochloride, a white to light brown, amorphous, and hygroscopic substance that is practically insoluble in water. Because of its high molecular mass and polar surface … Tenapanor
